Elevated Capital Advisors
CL icon

Elevated Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Elevated Capital Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$597 Hold
7
– – ﹤0.01% 804
2026
Q2 		$642 Hold
7
– – ﹤0.01% 785
2026
Q1 		$597 Sell
7
-9
-56% -$802 ﹤0.01% 776
2025
Q4 		$1.26K Buy
+16
New +$1.25K ﹤0.01% 686

Other funds holding CL

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Elevated Capital Advisors's CL Position: Q3 2026 in Review

Elevated Capital Advisors held its Colgate-Palmolive (CL) position steady in Q3 2026 at 7 shares worth $597. The position accounts for ﹤0.01% of the portfolio, ranked #804.

Elevated Capital Advisors first reported a position in CL in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.26K in Q4 2025. 1,712 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Elevated Capital Advisors held 7 shares of Colgate-Palmolive worth $597 as of Q3 2026.
  • Elevated Capital Advisors left its Colgate-Palmolive share count unchanged in Q3 2026.
  • Colgate-Palmolive made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q3 2026, its #804 holding.
  • Elevated Capital Advisors first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 4 quarters since.
  • Elevated Capital Advisors's Colgate-Palmolive position peaked at $1.26K in Q4 2025.
  • 1,712 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Elevated Capital Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.